Back
Corporate News
Mukka Proteins confirms no deviations in utilization of Rs 47 crore preferential issue funds
07-Nov-2026, 01:46
Mukka Proteins Limited informed the National Stock Exchange of India Limited and BSE Limited that there were no deviations or variations in the utilization of funds raised through a preferential issue of warrants, according to a filing on Saturday, November 7, 2026. The company raised Rs 47,00,00,000 on September 9, 2026, and the statement was reviewed by the Audit Committee.
